The crowd and panel gave Gilead a standing ovation after the full data from the Phase III PURPOSE trial was announced at AIDS 2024

Read also

Myeloma

Myeloma treatment HDP-101 put on FDA fast track

Evotec Announces Progress

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Evotec Announces Progress

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Tylenol (paracetamol)

Tylenol (paracetamol) fights autism claims, slams proposed FDA warning label as 'unsupported' by science